Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,919 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,501
Recruiting: 783
Ph III recruiting: 85
Growth YoY: +18.1%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

clinicaltrialsPublishedShowing 301–350 of 1,755 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05710380	MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy	recruiting	N/A	180	University of ChicagoOTHER	1	Sep 1, 2026	clinicaltrials
NCT07162194	MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial	recruiting	N/A	130	University of Southern CaliforniaOTHER	1	Sep 1, 2026	clinicaltrials